←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Base and Prime Editing
Peter Chen
PhD
🏢Beam Therapeutics🌐USA
Research Scientist in Base Editing Therapeutics
15
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Peter Chen has contributed to the development of multiplex base editing approaches for allogeneic CAR-T cells at Beam Therapeutics. His work supports the BEAM-201 multiply-edited CAR-T program for T cell leukemia. He is part of teams translating base editing into cancer cell therapies.
Share:
🧪Research Fields 研究领域
base editing
CAR-T multiplex editing
allogeneic cell therapy
cancer base editing
sickle cell editing
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Peter Chen 的研究动态
Follow Peter Chen's research updates
留下邮箱，当我们发布与 Peter Chen（Beam Therapeutics）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment